MR编号 | SE/H/1866/002 |
---|
药品名称 | octaplasLG |
---|
活性成分 | - human plasma proteins 0.0 mg/ml
|
---|
剂型 | Powder and solvent for solution for infusion |
---|
上市许可持有人 | Octapharma AB |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Austria (AT)
Octaplas LG 45 - 70 mg/ml Infusionslösung - France (FR)
- Spain (ES)
- Norway (NO)
- Finland (FI)
OctaplasLG Lyo - Hungary (HU)
OCTAPLASLG 45-70 mg/ml oldatos infúzió - Bulgaria (BG)
- Denmark (DK)
- Czechia (CZ)
octaplas LG LYO - Belgium (BE)
- Malta (MT)
octaplasLG Lyo, powder and solvent for solution for infusion - Netherlands (NL)
Omniplasma Lyo - Croatia (HR)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
|
---|
许可日期 | 2023/02/01 |
---|
最近更新日期 | 2025/01/27 |
---|
药物ATC编码 | - B05AA Blood substitutes and plasma protein fractions
|
---|
申请类型 | - TypeLevel1:Line Extension
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Biological: Blood Product
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|